SCHEMBL819987

SCHEMBL819987

O=C1CC/C=C\CC/C=C\CCC1

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 2/20 0.47
TRIM33 Q9UPN9 2/20 0.47
ALDH1A1 P00352 2/20 0.46
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1014666 1.00 TRIM24 (0.47) TRIM24TRIM33ALDH1A1MAPT
SCHEMBL16417515 1.00 TRIM24 (0.47) TRIM24TRIM33ALDH1A1MAPT
SCHEMBL812725 1.00 TRIM24 (0.47) TRIM24TRIM33ALDH1A1MAPT
SCHEMBL1014667 1.00 TRIM24 (0.47) TRIM24TRIM33ALDH1A1MAPT
SCHEMBL16417516 1.00 TRIM24 (0.47) TRIM24TRIM33ALDH1A1MAPT
SCHEMBL1011916 1.00 TRIM24 (0.47) TRIM24TRIM33ALDH1A1MAPT
SCHEMBL7917256 0.97
SCHEMBL16417514 0.97 TRIM24 (0.50) TRIM24TRIM33ALDH1A1MAPT
SCHEMBL1566776 0.97
SCHEMBL1566775 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023247599-A1 FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE FIRMENICH SA (CH) 2023-12-28 WO claimed
US-11691036-B2 Macrocyclic ketone as malodor counteracting ingredient FIRMENICH SA (CH) 2023-07-04 US claimed
US-20230105693-A1 ANTIMICROBIAL COMPOSITIONS FIRMENICH SA (CH) 2023-04-06 US claimed
US-20220249877-A1 MACROCYCLIC KETONE AS MALODOR COUNTERACTING INGREDIENT FIRMENICH SA (CH) 2022-08-11 US claimed
CN-114096235-A Antimicrobial compositions 弗门尼舍有限公司 2022-02-25 CN claimed
US-20190143151-A1 MACROCYCLIC KETONE AS MALODOR COUNTERACTING INGREDIENT FIRMENICH SA (CH) 2019-05-16 US claimed
EP-2723842-B2 CYCLODODECADIENONE DERIVATIVES AS PERFUMING INGREDIENTS FIRMENICH & CIE (CH) 2017-12-06 EP claimed
US-20170340905-A1 MACROCYCLIC KETONE AS MALODOR COUNTERACTING INGREDIENT FIRMENICH SA (CH) 2017-11-30 US claimed
US-9637707-B2 Cyclododecadienone derivatives as perfuming ingredients FIRMENICH SA (CH) 2017-05-02 US claimed
US-20160060569-A1 CYCLODODECADIENONE DERIVATIVES AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2016-03-03 US claimed
EP-2723842-A1 CYCLODODECADIENONE DERIVATIVES AS PERFUMING INGREDIENTS Firmenich SA (CH) 2014-04-30 EP claimed
US-20130338402-A1 PROCESS FOR PREPARING MACROCYCLIC KETONES BASF SE (DE) 2013-12-19 US claimed
WO-2013186238-A1 METHOD FOR PRODUCING MACROCYCLIC KETONES BASF SE (DE) 2013-12-19 WO claimed
WO-2012175437-A1 CYCLODODECADIENONE DERIVATIVES AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2012-12-27 WO claimed
EP-1667952-B1 METHOD FOR PRODUCING A KETONE BASF SE (DE) 2010-07-28 EP claimed
US-7754925-B2 Reacting aldehyde with hydrogen in presence of catalyst BASF AKTIENGESELLSCHAFT (DE) 2010-07-13 US claimed
US-7449606-B2 reacting cyclododecatriene with dinitrogen monoxide to obtain cyclododecadienone and hydrogenating the resulting cyclododecadienone; in particular to give cyclododecanone an important intermediate for the preparation of, for example, laurolactam BASF SE (DE) 2008-11-11 US claimed
US-20060281952-A1 Method for producing a ketone SCHLUMBERGER TECHNOLOGY CORPORATION 2006-12-14 US claimed
EP-1667952-A2 METHOD FOR PRODUCING A KETONE BASF AKTIENGESELLSCHAFT (DE) 2006-06-14 EP claimed
WO-2005030690-A2 METHOD FOR PRODUCING A KETONE BASF AKTIENGESELLSCHAFT (DE) 2005-04-07 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160060569-A1 CYCLODODECADIENONE DERIVATIVES AS PERFUMING INGREDIENTS CBR3, CFD, DRD3 TRIM24 4274/4885TRIM33 4459/4885ALDH1A1 1309/4885
US-20130338402-A1 PROCESS FOR PREPARING MACROCYCLIC KETONES AKR1C4, AKR1C1, AKR1C3 TRIM24 1201/4885TRIM33 2166/4885ALDH1A1 953/4885
US-20190143151-A1 MACROCYCLIC KETONE AS MALODOR COUNTERACTING INGREDIENT VKORC1, AKR1C4, PDK4 TRIM24 2550/4885TRIM33 1131/4885ALDH1A1 819/4885
US-11691036-B2 Macrocyclic ketone as malodor counteracting ingredient VKORC1, AKR1C4, PDK4 TRIM24 2550/4885TRIM33 1131/4885ALDH1A1 819/4885
US-20220249877-A1 MACROCYCLIC KETONE AS MALODOR COUNTERACTING INGREDIENT VKORC1, AKR1C4, PDK4 TRIM24 2550/4885TRIM33 1131/4885ALDH1A1 819/4885
US-20170340905-A1 MACROCYCLIC KETONE AS MALODOR COUNTERACTING INGREDIENT VKORC1, AKR1C4, PDK4 TRIM24 2550/4885TRIM33 1131/4885ALDH1A1 819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.